Literature DB >> 15832411

Two-dimensional polyacrylamide gel electrophoresis analysis of indomethacin-treated human colon cancer cells.

Yan-Li Cheng1, Gui-Ying Zhang, Zhi-Qiang Xiao, Fa-Qing Tang.   

Abstract

AIM: To establish the two-dimensional gel electrophoresis (2-DE) profiles of indomethacin (IN)-treated human colon cancer cell line HCT116, and to provide a new way to study its anti-tumor molecular mechanism through analyzing a variety of protein maps.
METHODS: Two-DE profiles of HCT116 were established in IN-treated and untreated groups. Total proteins were separated by immobilized pH gradient-based 2-DE. The gels were stained by silver, scanned by ImageScanner, and analyzed with Image Master software.
RESULTS: Clear background, well-resolved and reproducible 2-DE patterns of HCT116 cells were acquired in IN-treated and untreated group. The average deviation of spot position was 0.896+/-0.177 mm in IEF direction and 1.106+/-0.289 mm in SDS-PAGE direction respectively. In IN-treated group, 1169+/-36 spots were detected and 1061+/-32 spots were matched, the average matching rate was 90.6% in three gels. In untreated group, 1256+/-50 spots were detected and 1168+/-46 spots were matched, the average matching rate was 93.0% in three gels. Forty-five differential protein spots were displayed between IN-treated and untreated groups. Of which, 34 protein spots decreased and 9 showed higher expression in IN-treated group, and only two protein spots showed an expression in untreated cells.
CONCLUSION: Two-DE profiles of IN-treated and untreated HCT116 cells were established. Apparent 45 different protein spots were detected in IN-treated and untreated HCT116 cells. The analysis on differential protein spots may serve as a new way to study the molecule mechanism of IN-treated colon cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832411      PMCID: PMC4305628          DOI: 10.3748/wjg.v11.i16.2420

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  The role of separation science in proteomics research.

Authors:  H J Issaq
Journal:  Electrophoresis       Date:  2001-10       Impact factor: 3.535

2.  Positional reproducibility of protein spots in two-dimensional polyacrylamide gel electrophoresis using immobilised pH gradient isoelectric focusing in the first dimension: an interlaboratory comparison.

Authors:  J M Corbett; M J Dunn; A Posch; A Görg
Journal:  Electrophoresis       Date:  1994 Aug-Sep       Impact factor: 3.535

3.  A randomized trial of aspirin to prevent colorectal adenomas.

Authors:  John A Baron; Bernard F Cole; Robert S Sandler; Robert W Haile; Dennis Ahnen; Robert Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Michael Beach; Gerald J Beck; John H Bond; Tim Byers; E Robert Greenberg; Jack S Mandel; Norman Marcon; Leila A Mott; Loretta Pearson; Fred Saibil; Rosalind U van Stolk
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

4.  Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.

Authors:  G A Piazza; A K Rahm; T S Finn; B H Fryer; H Li; A L Stoumen; R Pamukcu; D J Ahnen
Journal:  Cancer Res       Date:  1997-06-15       Impact factor: 12.701

5.  Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study.

Authors:  G A Kune; S Kune; L F Watson
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

6.  Indomethacin and telomerase activity in tumor growth retardation.

Authors:  C Lönnroth; M Andersson; K Lundholm
Journal:  Int J Oncol       Date:  2001-05       Impact factor: 5.650

7.  Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.

Authors:  D J Elder; D E Halton; T E Crew; C Paraskeva
Journal:  Int J Cancer       Date:  2000-05-15       Impact factor: 7.396

8.  Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2.

Authors:  Hiroshi Nishihara; Shinae Kizaka-Kondoh; Paul A Insel; Lars Eckmann
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-01       Impact factor: 11.205

9.  Aspirin toxicity for human colonic tumor cells results from necrosis and is accompanied by cell cycle arrest.

Authors:  R Subbegowda; T O Frommel
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

10.  Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma.

Authors:  Tarek G Gharib; Guoan Chen; Hong Wang; Chiang-Ching Huang; Michael S Prescott; Kerby Shedden; David E Misek; Dafydd G Thomas; Thomas J Giordano; Jeremy M G Taylor; Sharon Kardia; John Yee; Mark B Orringer; Samir Hanash; David G Beer
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

View more
  1 in total

1.  Screening for novel protein targets of indomethacin in HCT116 human colon cancer cells using proteomics.

Authors:  Yan-Li Cheng; Gui-Ying Zhang; Cui Li; Jing Lin
Journal:  Oncol Lett       Date:  2013-09-03       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.